Infectious aetiology of prostatic disease and methods to identify causative agents

Details for Australian Patent Application No. 2005221729 (hide)

Owner Tissugen Pty Ltd

Inventors Cohen, Ronald Joseph; Garrett, Kerryn Lee; Shannon, Beverley Anne

Agent Davies Collison Cave

Pub. Number AU-B-2005221729

PCT Pub. Number WO2005/087929

Priority 60/612,688 24.09.04 US; 2004901359 15.03.04 AU

Filing date 15 March 2005

Wipo publication date 22 September 2005

Acceptance publication date 24 September 2009

International Classifications

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C07K 14/195 (2006.01) Peptides having more than 20 amino acids - from bacteria

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/087929 Priority application(s): WO2005/087929

24 September 2009 Application Accepted

  Published as AU-B-2005221729

21 January 2010 Standard Patent Sealed

14 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221733-An improved preparation of Atorvastatin

2005221728-Process and plant for conversion of waste material to liquid fuel